Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of GFAP and UCH-L1 Assays in Whole Blood to Optimizing Personalized Care for "Repeated Fallers" Hospitalized in Geriatric Wards

NCT07342023 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT07342023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07342023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of GFAP and UCH-L1 Assays in Whole Blood to Optimizing Personalized Care for "Repeated Fallers" Hospitalized in Geriatric Wards
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
August 31, 2028
Enrollment
770 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers / blood, fallers aged 60 years and older, intracranial bleeding